Peter Kenemans

15.2k total citations · 2 hit papers
304 papers, 11.6k citations indexed

About

Peter Kenemans is a scholar working on Genetics, Reproductive Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Kenemans has authored 304 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Genetics, 77 papers in Reproductive Medicine and 72 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Kenemans's work include Estrogen and related hormone effects (66 papers), Menopause: Health Impacts and Treatments (65 papers) and Ovarian cancer diagnosis and treatment (63 papers). Peter Kenemans is often cited by papers focused on Estrogen and related hormone effects (66 papers), Menopause: Health Impacts and Treatments (65 papers) and Ovarian cancer diagnosis and treatment (63 papers). Peter Kenemans collaborates with scholars based in Netherlands, United States and United Kingdom. Peter Kenemans's co-authors include Marius J. van der Mooren, René H.M. Verheijen, Gerard J. van Kamp, Chris J.L.M. Meijer, Silvia von Mensdorff‐Pouilly, Feja J. Voorhorst, Coen D.A. Stehouwer, Jan M.M. Walboomers, Rob A. Verstraeten and Velja Mijatovic and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Peter Kenemans

301 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1999 537 citations Marielle Nobbenhuis, Jan M.M. Walboomers et al. The Lancet profile →
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

2001 521 citations Jurgen M.J. Piek, P. J. van Diest et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kenemans Netherlands	56	2.7k	2.6k	2.6k	2.4k	2.4k	304	11.6k
D. Wallwiener Germany	54	1.4k 0.5×	1.3k 0.5×	2.5k 1.0×	854 0.4×	5.0k 2.1×	608	12.8k
Ross S. Berkowitz United States	66	5.4k 2.0×	1.5k 0.6×	4.6k 1.8×	1.0k 0.4×	2.7k 1.1×	445	18.7k
Peter E. Schwartz United States	53	3.1k 1.2×	1.1k 0.4×	2.7k 1.0×	1.4k 0.6×	3.4k 1.4×	258	10.3k
Christian Marth Austria	61	3.1k 1.2×	1.6k 0.6×	5.8k 2.2×	1.0k 0.4×	5.3k 2.2×	411	14.0k
Sërgio Pecorelli Italy	50	4.2k 1.6×	630 0.2×	2.1k 0.8×	1.6k 0.7×	2.9k 1.2×	178	10.6k
René H.M. Verheijen Netherlands	49	3.9k 1.5×	1.1k 0.4×	1.7k 0.7×	3.6k 1.5×	2.0k 0.8×	187	10.2k
Ronald D. Alvarez United States	63	3.1k 1.2×	3.5k 1.3×	4.6k 1.8×	2.0k 0.8×	4.3k 1.8×	340	12.5k
Stephen C. Rubin United States	62	6.4k 2.4×	1.7k 0.7×	2.5k 1.0×	915 0.4×	6.0k 2.5×	276	15.3k
Thomas Krausz United States	60	1.3k 0.5×	637 0.2×	3.5k 1.4×	1.4k 0.6×	3.4k 1.4×	222	13.4k
Daisuke Aoki Japan	47	3.6k 1.3×	785 0.3×	3.6k 1.4×	1.7k 0.7×	2.5k 1.0×	440	11.0k

Countries citing papers authored by Peter Kenemans

Since Specialization

Citations

This map shows the geographic impact of Peter Kenemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kenemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kenemans more than expected).

Fields of papers citing papers by Peter Kenemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kenemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kenemans. The network helps show where Peter Kenemans may publish in the future.

Co-authorship network of co-authors of Peter Kenemans

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kenemans. A scholar is included among the top collaborators of Peter Kenemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kenemans. Peter Kenemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diest, P. J. van, et al.. (2008). The Prognostic and Clinical Value of Morphometry and DNA Cytometry in Borderline Ovarian Tumors: A Prospective Study. International Journal of Gynecological Pathology. 28(1). 35–40. 7 indexed citations

Kenemans, Peter & Leon Speroff. (2005). Tibolon: Klinische Empfehlungen und praktische Richtlinien. Journal für Kardiologie (Krause & Pachernegg GmbH). 12(2). 10–15.

Post, Marinka S., Marius J. van der Mooren, W.M. van Baal, et al.. (2003). Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study. American Journal of Obstetrics and Gynecology. 189(5). 1221–1227. 52 indexed citations

Smolders, R.G.V., Marius J. van der Mooren, Tom Teerlink, et al.. (2003). A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertility and Sterility. 79(2). 261–267. 27 indexed citations

Piek, Jurgen M.J., Brenda Hermsen, René H.M. Verheijen, et al.. (2003). Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study. Familial Cancer. 2(2). 73–78. 50 indexed citations

Smolders, R.G.V., et al.. (2002). 17β-Estradiol induces a rapid, endothelium-dependent, sex-specific vasodilatation in spontaneous constricted rat arterioles. American Journal of Obstetrics and Gynecology. 187(2). 375–381. 10 indexed citations

Shaw, Patricia A., Esther M. John, Ronald P. Zweemer, et al.. (2002). Histopathologic Features of Genetically Determined Ovarian Cancer. International Journal of Gynecological Pathology. 21(4). 407–411. 87 indexed citations

Crosignani, Pier Giorgio, Martin Birkhäuser, John A. Collins, et al.. (2000). Continuation rates for oral contraceptives and hormone replacement therapy. Human Reproduction. 15(8). 1865–1871. 16 indexed citations

Kenemans, Peter, et al.. (2000). Postmenopausal sex hormones and cancer of the endometrium and breast. The Journal of the British Menopause Society. 6(2_suppl). 4–9. 2 indexed citations

10.

Nobbenhuis, Marielle, Jan M.M. Walboomers, Theo J.M. Helmerhorst, et al.. (1999). Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. The Lancet. 354(9172). 20–25. 537 indexed citations breakdown →

11.

Kamp, Gerard J. van, et al.. (1999). Quantification of MUC1 in breast cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 83(1). 67–75. 13 indexed citations

12.

Bonfrèr, Johannes M.G., et al.. (1996). CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?. Cancer. 78(1). 118–127. 1 indexed citations

13.

Bonfrèr, Johannes M.G., et al.. (1996). CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?. Cancer. 78(1). 118–127. 27 indexed citations

14.

Veenhuizen, Ruth B., et al.. (1996). Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma. British Journal of Cancer. 73(11). 1387–1392. 19 indexed citations

15.

Buist, Marrije R., Peter Kenemans, Gerard J. van Kamp, & Hidde J. Haisma. (1995). Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays. Cancer Immunology Immunotherapy. 40(1). 24–30. 19 indexed citations

16.

Kenemans, Peter, et al.. (1994). Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer. 74(8). 2314–2320. 19 indexed citations

17.

Kenemans, Peter, Th. Wobbes, C.M.G. Thomas, et al.. (1992). Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal Adenocarcinomas. Tumor Biology. 13(1-2). 18–26. 51 indexed citations

18.

Nijman, Hans W., Curt W. Burger, Jan P. A. Baak, et al.. (1992). Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. European Journal of Cancer. 28(12). 1971–1973. 52 indexed citations

19.

Massuger, Leon F.A.G., Roland A. M. J. Claessens, Koon Y. Pak, et al.. (1991). Tissue distribution of technetium 99m indium 111 labelled and iodine 123 ov tl 3 fab in ovarian carcinoma bearing nude mice. Nuclear Medicine and Biology. 18(1). 77–84. 4 indexed citations

20.

Kenemans, Peter, et al.. (1983). Scanning electron microscopy of exfoliative cervical cytology.. PubMed. 1899–909. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact